GeneFerm Biotechnology Market Cap

GeneFerm Biotechnology has a market cap or net worth of 1.58 billion as of April 28, 2026. Its market cap has decreased by -31.14% in one year.

Market Cap

1.58B

Enterprise Value

1.63B

Revenue

677.10M

Ranking

n/a

PE Ratio

54.80

Stock Price

38.10

Market Cap Chart

Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.58B, a decrease of -27.25%. That is a compound annual growth rate of -3.21%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	1.58B	-20.93%
Dec 31, 2025	2.00B	2.66%
Dec 31, 2024	1.95B	-36.91%
Dec 29, 2023	3.09B	11.36%
Dec 30, 2022	2.77B	53.32%
Dec 30, 2021	1.81B	122.87%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
InnoPharmax	1.66B
Tien Liang BioTech	1.75B
TSH Biopharm Corporation	1.96B
Winston Medical Supply	1.29B
DV Biomed	1.21B
Excelsior Biopharma	1.18B
Johnson Chemical Pharmaceutical Works	2.41B
Prince Pharmaceutical	1.08B

Market Cap Rankings